Other
Alcohol Consumption
0
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
Alcohol Consumption is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
15
clinical trials
Completed9 · 60%
Recruiting2 · 13%
Terminated1 · 7%
Unknown status1 · 7%
Not yet recruiting1 · 7%
Active, not recruiting1 · 7%
Clinical Trials
Trial Activity
15 trials
Cannabis' Impact on Alcohol Consumption
Recruiting·—·Phase 2·NCT05389930·350 enrolled
Rimonabant to Reduce Alcohol Consumption
Completed·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 2·NCT00075205·54 enrolled
Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling
Completed·—·N/A·NCT02654236·30 enrolled
Varenicline to Reduce Alcohol Consumption in Heavy Drinkers
Completed·—·Phase 1/2·NCT00695500·50 enrolled
Effect of Alcohol Consumption on the Success Rates
Unknown status·—·N/A·NCT06201871·70 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)